Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 3rd Edition
The urgent demand for effective and safe therapies—particularly for aggressive cancers, where delays in diagnosis and treatment can turn manageable conditions into fatal ones—continues to drive innovation in drug research. Key areas of current focus include the development of novel therapeutic molec...
Tallennettuna:
| Aineistotyyppi: | Online |
|---|---|
| Kieli: | englanti |
| Julkaistu: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| Aiheet: | |
| Linkit: | ONIX_20260416T142754_9783725855650_42 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
| Yhteenveto: | The urgent demand for effective and safe therapies—particularly for aggressive cancers, where delays in diagnosis and treatment can turn manageable conditions into fatal ones—continues to drive innovation in drug research. Key areas of current focus include the development of novel therapeutic molecules, advanced drug delivery systems, personalized medicine, and the integration of digital technologies into treatment strategies. Progress in these domains requires the close integration of multiple scientific disciplines and industrial sectors, ensuring a comprehensive approach to drug discovery and development. This third edition, dedicated to the Interdisciplinary Conference on Drug Sciences, ACCORD 2024, aims to highlight research that has contributed to the conception, design, and development of new drug substances and formulations. The topics explored in this Special Issue include the identification of novel molecular drug targets, evaluation of drug–protein interactions, modeling and optimization of functional activity, pre-formulation studies, pharmaceutical carrier design, and preclinical investigations. The Special Issue assembles a diverse collection of innovative studies that span critical stages of drug discovery, formulation, targeted delivery, and therapeutic monitoring. |
|---|